In this 60-min roundtable discussion expert panelists discuss challenges, promising tools, trends and the future of CAR-T therapies.
To watch the discussion on-demand or to access its written summary (PDF), please fill out the form on the right. Please don’t forget to let us know if you would like to receive future emails from Lonza about related content, events, product news or application highlights.
Topics include:
- Key considerations for advancing CAR/TCR therapies to the clinic and commercialization
- Major pain points in CAR-T processes that need further development
- Advantages and challenges of closed system transduction/transfection platforms
- Selecting raw materials and GMP ancillary choices
- The future of CRISPR/CAS based systems
Panelists:
- Isabelle Rivière
Director, Cell Therapy and Cell Engineering Facility, Memorial Sloan Kettering Cancer Center - Metin Kurtoglu
Chief GMP Manufacturing and Chief Medical Officer, Cartesian Therapeutics - Tariq Haq
Head of Cell and Gene Therapy Segment Marketing at Lonza Bioscience Solutions
This event has been produced in collaboration with BioInsights.